New Melanoma Treatment Vaccine Shows Promise in Trial
FRIDAY, Dec. 15, 2023 (HealthDay News) — A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck’s cancer drug Keytruda were 49% less likely to die or have their cancer return afterContinue Reading










